141 related articles for article (PubMed ID: 14965442)
1. ING-1(heMAb), a monoclonal antibody to epithelial cell adhesion molecule, inhibits tumor metastases in a murine cancer model.
Ruan HH; Scott KR; Bautista E; Ammons WS
Neoplasia; 2003; 5(6):489-94. PubMed ID: 14965442
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo pharmacology and pharmacokinetics of a human engineered monoclonal antibody to epithelial cell adhesion molecule.
Ammons WS; Bauer RJ; Horwitz AH; Chen ZJ; Bautista E; Ruan HH; Abramova M; Scott KR; Dedrick RL
Neoplasia; 2003; 5(2):146-54. PubMed ID: 12659687
[TBL] [Abstract][Full Text] [Related]
3. ING-1, a monoclonal antibody targeting Ep-CAM in patients with advanced adenocarcinomas.
de Bono JS; Tolcher AW; Forero A; Vanhove GF; Takimoto C; Bauer RJ; Hammond LA; Patnaik A; White ML; Shen S; Khazaeli MB; Rowinsky EK; LoBuglio AF
Clin Cancer Res; 2004 Nov; 10(22):7555-65. PubMed ID: 15569986
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of a dual cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM expressing tumor cells.
Schanzer JM; Fichtner I; Baeuerle PA; Kufer P
J Immunother; 2006; 29(5):477-88. PubMed ID: 16971804
[TBL] [Abstract][Full Text] [Related]
5. Exchanging human Fcgamma1 with murine Fcgamma2a highly potentiates anti-tumor activity of anti-EpCAM antibody adecatumumab in a syngeneic mouse lung metastasis model.
Lutterbuese P; Brischwein K; Hofmeister R; Crommer S; Lorenczewski G; Petersen L; Lippold S; da Silva A; Locher M; Baeuerle PA; Schlereth B
Cancer Immunol Immunother; 2007 Apr; 56(4):459-68. PubMed ID: 16937114
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and safety study of subcutaneously administered weekly ING-1, a human engineere monoclonal antibody targeting human EpCAM, in patients with advanced solid tumors.
Goel S; Bauer RJ; Desai K; Bulgaru A; Iqbal T; Strachan BK; Kim G; Kaubisch A; Vanhove GF; Goldberg G; Mani S
Ann Oncol; 2007 Oct; 18(10):1704-7. PubMed ID: 17693421
[TBL] [Abstract][Full Text] [Related]
7. Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy.
Thurm H; Ebel S; Kentenich C; Hemsen A; Riethdorf S; Coith C; Wallwiener D; Braun S; Oberhoff C; Jänicke F; Pantel K
Clin Cancer Res; 2003 Jul; 9(7):2598-604. PubMed ID: 12855636
[TBL] [Abstract][Full Text] [Related]
8. The level of MHC class I expression on murine adenocarcinoma can change the antitumor effector mechanism of immunocytokine therapy.
Imboden M; Murphy KR; Rakhmilevich AL; Neal ZC; Xiang R; Reisfeld RA; Gillies SD; Sondel PM
Cancer Res; 2001 Feb; 61(4):1500-7. PubMed ID: 11245457
[TBL] [Abstract][Full Text] [Related]
9. Naturally occurring antibodies to epithelial cell adhesion molecule (EpCAM).
Kirman I; Jenkins D; Fowler R; Whelan RL
Dig Dis Sci; 2003 Dec; 48(12):2306-9. PubMed ID: 14714617
[TBL] [Abstract][Full Text] [Related]
10. Letter to the editor: efficacy and safety of anti-Trop antibodies, R. Cubas, M. Li, C. Chen and Q. Yao, Biochim Biophys Acta 1796 (2009) 309-1.
Trerotola M; Guerra E; Alberti S
Biochim Biophys Acta; 2010 Apr; 1805(2):119-20; author reply 121-2. PubMed ID: 20079406
[TBL] [Abstract][Full Text] [Related]
11. Epithelial glycoprotein-2 expression is subject to regulatory processes in epithelial-mesenchymal transitions during metastases: an investigation of human cancers transplanted into severe combined immunodeficient mice.
Jojović M; Adam E; Zangemeister-Wittke U; Schumacher U
Histochem J; 1998 Oct; 30(10):723-9. PubMed ID: 9873999
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.
Bellone S; Siegel ER; Cocco E; Cargnelutti M; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Int J Gynecol Cancer; 2009 Jul; 19(5):860-6. PubMed ID: 19574774
[TBL] [Abstract][Full Text] [Related]
13. Expression of epithelial-cell adhesion molecule (Ep-CAM) in small cell lung cancer as defined by monoclonal antibodies 17-1A and BerEP4.
Brezicka T
Acta Oncol; 2005; 44(7):723-7. PubMed ID: 16227163
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment.
Naundorf S; Preithner S; Mayer P; Lippold S; Wolf A; Hanakam F; Fichtner I; Kufer P; Raum T; Riethmüller G; Baeuerle PA; Dreier T
Int J Cancer; 2002 Jul; 100(1):101-10. PubMed ID: 12115595
[TBL] [Abstract][Full Text] [Related]
15. Specific targeting of Ep-CAM in various carcinomas by novel monoclonal antibodies.
Sithambaram D; Palanivelu S; Subramanian K; Sahoo S; Verma RS
Hybridoma (Larchmt); 2011 Dec; 30(6):511-8. PubMed ID: 22149275
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic window of MuS110, a single-chain antibody construct bispecific for murine EpCAM and murine CD3.
Amann M; Brischwein K; Lutterbuese P; Parr L; Petersen L; Lorenczewski G; Krinner E; Bruckmeier S; Lippold S; Kischel R; Lutterbuese R; Kufer P; Baeuerle PA; Schlereth B
Cancer Res; 2008 Jan; 68(1):143-51. PubMed ID: 18172306
[TBL] [Abstract][Full Text] [Related]
17. Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small-animal PET/CT and NIRF.
Hall MA; Pinkston KL; Wilganowski N; Robinson H; Ghosh P; Azhdarinia A; Vazquez-Arreguin K; Kolonin AM; Harvey BR; Sevick-Muraca EM
J Nucl Med; 2012 Sep; 53(9):1427-37. PubMed ID: 22872743
[TBL] [Abstract][Full Text] [Related]
18. Cure of metastatic human colonic cancer in mice with radiolabeled monoclonal antibody fragments.
Behr TM; Blumenthal RD; Memtsoudis S; Sharkey RM; Gratz S; Becker W; Goldenberg DM
Clin Cancer Res; 2000 Dec; 6(12):4900-7. PubMed ID: 11156250
[TBL] [Abstract][Full Text] [Related]
19. An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer.
Liao MY; Lai JK; Kuo MY; Lu RM; Lin CW; Cheng PC; Liang KH; Wu HC
Oncotarget; 2015 Sep; 6(28):24947-68. PubMed ID: 26317650
[TBL] [Abstract][Full Text] [Related]
20. EpCAM- and EGFR-targeted selective gene therapy for biliary cancers using Z33-fiber-modified adenovirus.
Kawashima R; Abei M; Fukuda K; Nakamura K; Murata T; Wakayama M; Seo E; Hasegawa N; Mizuguchi H; Obata Y; Hyodo I; Hamada H; Yokoyama KK
Int J Cancer; 2011 Sep; 129(5):1244-53. PubMed ID: 21710497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
